Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.

Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.

Item
http://www.wikidata.org/entity/Q33436643
Statistical aspects of omics data analysis using the random compound covariateVeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab.Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC.Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancerMass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies.Lung cancer proteomics: recent advances in biomarker discoveryThe Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer.Added value of a serum proteomic signature in the diagnostic evaluation of lung nodulesImmunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.Bevacizumab in non-small-cell lung cancer: a review.
P2860

Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.

Item
http://www.wikidata.org/entity/Q33436643
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Classification by mass spectro ...... erlotinib-containing regimen.
@ast
Classification by mass spectro ...... erlotinib-containing regimen.
@en
type
label
Classification by mass spectro ...... erlotinib-containing regimen.
@ast
Classification by mass spectro ...... erlotinib-containing regimen.
@en
prefLabel
Classification by mass spectro ...... erlotinib-containing regimen.
@ast
Classification by mass spectro ...... erlotinib-containing regimen.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Classification by mass spectro ...... erlotinib-containing regimen.
@en
P2093
P2860
P304
P31
P356
10.1097/JTO.0B013E3181A526B3
P433
P478
P50
P577
P698
P932